topline results - Robuta Search

https://www.biospace.com/press-releases/amneal-highlights-positive-topline-results-from-confirmatory-clinical-study-of-biosimilar-candidate-to-xolairr-omalizumab-developed-by-kashiv-biosciences Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate... topline results https://finviz.com/news/339956/goss-announces-topline-results-for-phase-3-prosera-trial-levi-korsinsky-llp GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP Stock screener for investors and traders, financial visualizations. topline results phase 3 https://www.biospace.com/elite-pharma-reports-positive-topline-results-from-a-pivotal-bioequivalence-study Elite Pharma Reports Positive Topline Results From A Pivotal Bioequivalence Study - BioSpace topline results https://finviz.com/news/330206/goss-announces-topline-results-for-phase-3-prosera-trial-levi-korsinsky-llp GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP Stock screener for investors and traders, financial visualizations. topline results phase 3 https://www.globenewswire.com/de/news-release/2023/11/28/2786600/0/en/argenx-reports-topline-results-from-advance-sc-study-of-vyvgart-hytrulo-in-primary-immune-thrombocytopenia.html argenx Reports Topline Results from ADVANCE-SC Study of Study did not meet primary or secondary endpointsFavorable safety and tolerability profile consistent with previous clinical trials Conference call... topline results argenx reports advance sc https://www.sciencetimes.com/articles/33260/20210905/imv-released-final-topline-results-decide1-clinical-trial.htm IMV Released Final Topline Results for Its DeCidE1 Clinical Trial Sep 5, 2021 - Biopharmaceutical firm IMV has released the final topline results for its DeCidE1 Phase 2 clinical trial. topline results imv released final clinical https://www.biospace.com/annexon-announces-positive-topline-results-from-pivotal-phase-3-trial-for-first-in-class-c1q-blocking-antibody-anx005-in-guillain-barre-syndrome Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q... Jun 4, 2024 - Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage platform of novel therapies for people living with devastating classical... https://www.biospace.com/scpharmaceuticals-announces-positive-topline-study-results-for-scp-111-furosemide-80-mg-1-ml-autoinjector scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL)... https://www.biospace.com/press-releases/keros-therapeutics-announces-initial-topline-results-from-the-phase-1-clinical-trial-of-ker-065-in-healthy-volunteers Keros Therapeutics Announces Initial Topline Results from the Phase 1 Clinical Trial of KER-065 in... https://www.prnewswire.com/news-releases/telix-announces-positive-topline-results-of-zircon-phase-iii-kidney-cancer-imaging-study-301669685.html Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all... https://www.prnewswire.co.uk/news-releases/obi-pharma-reports-topline-results-from-obi-822821-randomized-controlled-phase-23-clinical-trial-in-patients-with-metastatic-breast-cancer-569628221.html OBI Pharma Reports Topline Results From OBI-822/821 Randomized Controlled Phase 2/3 Clinical Trial... /PRNewswire/ -- OBI Pharma, Inc., a Taiwan biotech company (TPex: 4174), today announced the topline results of the Phase 2/3 study of OBI-822/821 (formerly...